RESUMEN
We have developed an improved method for measuring the filamentous (F) actin content of human blood polymorphonuclear leukocytes (PMNs). The essential feature of the method is the immediate fixation of the F-actin cytoskeleton. Fresh whole blood (100 microliters) is shock-cooled by the addition of 1.0 ml of a mixture of 18.75% glycerol and 5% formaldehyde in phosphate buffer pre-cooled to -8 degrees C and subsequently fixed at 4 degrees C for 15 min. After lysis in distilled water and removal of the red blood cells by centrifugation, the F-actin cytoskeleton of the PMNs is stained with fluorescein isothiocyanate (FITC)-phalloidin and quantified by means of flow cytometry. In healthy test subjects, PMN stimulation by the chemotactic peptide formyl-methionyl-leucyl-phenylalanine (FMLP) for 20 s resulted in a significantly increased F-actin assembly, while in patients with multiple organ failure, two subpopulations arose: one with greater F-actin content and a second with lower F-actin content in comparison with the unstimulated blood sample. This simple and fast method may be a useful tool in basic and clinical research.
Asunto(s)
Actinas/sangre , Citometría de Flujo/métodos , Neutrófilos/química , Adulto , Citoesqueleto/química , Femenino , Fluoresceína-5-Isotiocianato/química , Humanos , Masculino , Insuficiencia Multiorgánica/sangre , N-Formilmetionina Leucil-Fenilalanina/farmacología , Neutrófilos/efectos de los fármacos , Faloidina/química , Valores de Referencia , Coloración y EtiquetadoRESUMEN
OBJECTIVES: We investigated the association of impaired blood polymorphonuclear leukocyte (PMN) migration with the incidence of bacterial infections in patients with severe trauma. METHOD: Twenty-six intensive-care patients with different injury severity scores were enrolled in a prospective study. PMN migration was measured daily using 300 microl fresh whole blood in a membrane filter assay. Migration was evaluated in an automated image analyzer that recorded numbers and distribution of the immigrant PMNs within a filter. The relevant parameter was the percentage of PMNs that migrated from the blood samples into the filters upon f-Met-Leu-Phe stimulation. RESULTS: Nine patients developed posttraumatic infections verified microbiologically. These patients showed a reduced PMN migratory capacity in comparison with the 17 patients without infections. A migrating portion of six per cent or less at least three days in succession preceded infections by one to 19 days and indicated infection in eight true positive versus three false positive cases, and 14 true negative versus one false negative case, i.e. specificity was 82.3% and sensitivity 88.8%, p=0.0008. Trauma severity had no influence on PMN migration. CONCLUSIONS: Trauma patients with impaired PMN migration are at risk for bacterial infections. Whole-blood migration tests can define the infection risk and thus may be useful predictive markers for infections.
Asunto(s)
Infecciones Bacterianas/epidemiología , Movimiento Celular/inmunología , Neutrófilos/inmunología , Adulto , Anciano , Infecciones Bacterianas/inmunología , Biomarcadores/sangre , Femenino , Humanos , Incidencia , Puntaje de Gravedad del Traumatismo , Unidades de Cuidados Intensivos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Estadísticas no ParamétricasRESUMEN
The aim of the study was to demonstrate an activation of polymorpho-nuclear leukocytes (PMNs) in chronic progressive atherosclerosis (ATH). A group of patients with ATH, and a group of ATH patients under aspirin (ASA) therapy were compared with control persons without atherosclerotic alterations (healthy controls). Each group comprised 15 male age-matched subjects. The following inflammatory parameters related to PMN activities were measured: the polymorphonuclear leukocyte (PMN) blood count; blood PMN migration and reactive oxygen species release in vitro; the blood levels of PMN elastase, malondialdehyde, antibodies to oxidized LDL and soluble ICAM-1. In ATH patients, the PMN blood counts and the share of blood PMNs migrating upon platelet activating factor and leukotriene B4 stimulation were significnatly above the values of the healthy controls, while the other parameters were not significantly altered. ASA treatment attenuated the inflammatory response and reduced the differences between ATH and the healthy controls. It can be concluded that, in patients with chronic progressive atherosclerosis, PMNs are involved in the inflammatory process underlying the disease.
Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Arteriosclerosis/sangre , Arteriosclerosis/tratamiento farmacológico , Aspirina/farmacología , Neutrófilos/efectos de los fármacos , Estudios de Casos y Controles , Quimiotaxis de Leucocito/efectos de los fármacos , Humanos , Técnicas In Vitro , Inflamación/sangre , Inflamación/tratamiento farmacológico , Molécula 1 de Adhesión Intercelular/sangre , Recuento de Leucocitos , Elastasa de Leucocito/sangre , Lipoproteínas LDL/sangre , Masculino , Malondialdehído/sangre , Persona de Mediana Edad , Neutrófilos/fisiología , Especies Reactivas de Oxígeno/metabolismoRESUMEN
Recent worldwide terrorist acts and hoaxes have heightened awareness that incidents involving weapons of mass destruction (WMD) may occur in the United States. With federal funding assistance, local domestic preparedness programs have been initiated to train and equip emergency services and emergency department personnel in the management of large numbers of casualties exposed to nuclear, biological, or chemical (NBC) agents. Hospital pharmacies will be required to provide antidotes, antibiotics, antitoxins, and other pharmaceuticals in large amounts and have the capability for prompt procurement. Pharmacists should become knowledgeable in drug therapy of NBC threats with respect to nerve agents, cyanide, pulmonary irritants, radionucleotides, anthrax, botulism, and other possible WMD.
Asunto(s)
Guerra Biológica , Guerra Química , Guerra Nuclear , Servicio de Farmacia en Hospital/organización & administración , Animales , Antídotos/provisión & distribución , Sustancias para la Guerra Química , HumanosAsunto(s)
Bibliografías como Asunto , Dermatología , Adulto , Dermatología/historia , Femenino , Historia de la Medicina , Humanos , PoloniaAsunto(s)
Dedos , Histiocitoma Fibroso Benigno , Neoplasias Cutáneas , Femenino , Histiocitoma Fibroso Benigno/diagnóstico , Histiocitoma Fibroso Benigno/patología , Histiocitoma Fibroso Benigno/cirugía , Humanos , Persona de Mediana Edad , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/cirugíaRESUMEN
Prior to the 1950's, there existed no formal system for poison prevention or treatment in the US. Estimates place the number of pediatric poisoning fatalities at over 400/y at that time. After World War II, urbanization and modern technological methods brought forth over 250,000 different brand name products on the market. Health care professionals presented with cases of acute poisoning usually had little knowledge of what ingredients were contained in these new products, making it difficult to treat these patients. In the 1930's, pharmacist Louis Gdalman established a poison information service at St Luke's hospital. Because of Gdalman's training in pharmacy and chemistry, physicians throughout Chicago and the US called on him in search of assistance. In the late 1940's, Gdalman began recording information on small cards, and developed a standard data collection from. By the 1950's he had established an extensive library on the management of acute and chronic poisonings. In 1948, a national effort to reduce the number of accidents in children was started by the American Academy of Pediatrics, and a committee was formed in Chicago to address this public safety need. In November, 1953, the poison center at Presbyterian-St Luke's Hospital was formally recognized, and the poison program model spread nationwide. As the number of poison centers grew, coordination was achieved through the National Clearing House for Poison Control Centers, founded in 1957, and the American Association of Poison Control Centers, created in 1958. By 1970, the number of poison centers in the US was reported to be 597. The need for large and better centers led to regional poison control centers. Other outgrowths were the formation of the National Poison Prevention Week Council, the enactment of the Poison Prevention Packaging Act, development of "Mr. Yuk" and other symbols, and formation of the National Animal Poison Control Center. As a result, the number of children dying from accidental poisoning has dropped to under 50/y.
Asunto(s)
Centros de Control de Intoxicaciones/historia , Intoxicación/historia , Chicago , Niño , Historia del Siglo XX , Humanos , Intoxicación/prevención & controlRESUMEN
Five patients presented to the emergency department (ED) following exposure in an enclosed space to methylene chloride (dichloromethane), used for removing paint. Two workers and three rescuers were involved. Two rescuers complained only of dizziness and mild nausea, and were subsequently discharged from the ED. One rescuer was asymptomatic. Worker no. 1 arrived in cardiac arrest and eventually died in the ED despite resuscitation efforts. Worker no. 2 also presented to the ED in cardiac arrest, and was successfully resuscitated to pulse and blood pressure. However, he never regained consciousness or spontaneous respirations, and died on the fourth day. Of interest is that worker no. 2's carboxyhemoglobin level increased from 2% to 8% over the 9 hours following admission, despite administration of 40% to 50% oxygen by endotracheal tube. Among the conclusions that can be drawn are (1) the cause of death in these patients was not carbon monoxide poisoning, but solvent-induced narcosis; (2) carboxyhemoglobin levels may continue to rise following cessation of exposure, despite administration of high flow oxygen; (3) rescuers can easily become victims if proper protective clothing and respirators are not worn.
Asunto(s)
Cloruro de Metileno/envenenamiento , Exposición Profesional , Solventes/envenenamiento , Adulto , Carboxihemoglobina/análisis , Cuidados Críticos , Humanos , Masculino , Intoxicación/sangre , Intoxicación/mortalidad , Intoxicación/terapiaRESUMEN
A 3-y-old child ingested SUCCIMER capsules to receive a dose of 185 mg dimercaptosuccinic acid/kg body weight. No adverse effects occurred.
Asunto(s)
Antídotos/efectos adversos , Quelantes/efectos adversos , Intoxicación por Plomo/tratamiento farmacológico , Succímero/efectos adversos , Antídotos/administración & dosificación , Catárticos/uso terapéutico , Carbón Orgánico/uso terapéutico , Quelantes/administración & dosificación , Preescolar , Femenino , Humanos , Plomo/sangre , Sorbitol/uso terapéutico , Succímero/administración & dosificaciónRESUMEN
A 53-y-o patient presented approximately 2 h after taking her first dose of nefazadone. Chief complaint was lip smacking with hand and arm gesturing. The patient also took 25 mg meclizine which she had used before with no adverse effects. Diphenhydramine followed by benztropine led to resolution of symptoms within 1 h. Patient subsequently used meclizine with no untoward reactions. Nefazadone should be added to the list of agents that cause acute dystonic reactions.
Asunto(s)
Benzotropina/uso terapéutico , Difenhidramina/uso terapéutico , Distonía/inducido químicamente , Meclizina/farmacología , Triazoles/envenenamiento , Antidepresivos de Segunda Generación/envenenamiento , Antieméticos/uso terapéutico , Interacciones Farmacológicas , Distonía/diagnóstico , Distonía/terapia , Femenino , Humanos , Persona de Mediana Edad , Parasimpatolíticos/uso terapéutico , Piperazinas , Factores de TiempoRESUMEN
Four cases are presented, one involving extravasation of a dopamine and dobutamine solution in the arm and three involving accidental digital injection of epinephrine into the thumb. In three cases, local infiltration of terbutaline resulted in dramatic reversal of vasospasm and ischemia. In the remaining case the use of terbutaline resulted in minor clinical improvement. These are the first reported cases involving the successful treatment of peripheral ischemia with subcutaneous terbutaline. This experience suggests that terbutaline may be an effective alternative for treatment of peripheral ischemia when phentolamine is not available.
Asunto(s)
Agonistas Adrenérgicos beta/uso terapéutico , Brazo/irrigación sanguínea , Isquemia/inducido químicamente , Isquemia/tratamiento farmacológico , Terbutalina/uso terapéutico , Pulgar/irrigación sanguínea , Adolescente , Adulto , Anciano , Cardiotónicos/efectos adversos , Dobutamina/efectos adversos , Dopamina/efectos adversos , Tratamiento de Urgencia , Epinefrina/efectos adversos , Extravasación de Materiales Terapéuticos y Diagnósticos/complicaciones , Femenino , Humanos , Inyecciones Subcutáneas , Masculino , Vasoconstrictores/efectos adversosRESUMEN
Infectious complications are still a major cause of morbidity and mortality after organ transplantation, and early therapy would certainly reduce the risk associated with severe infections. We therefore investigated the significance of polymorphonuclear leukocyte (PMN) functional tests as predictive markers for infection in transplant patients under immunosuppressive therapy in a longitudinal study. In 41 patients, blood PMN migration and reactive oxygen species release, the blood levels of PMN elastase, malondialdehyde, neopterin, sICAM-1 and sVCAM-1, and urine neopterine were measured in 3- and 4-day intervals after liver-, kidney-, kidney-pancreas-, and heart and lung transplantation. PMN migration was determined in whole blood and estimated by the amount of PMNs to penetrate into a membrane filter upon FMLP stimulation. Three groups of patients were formed according to their postoperative course. Group I patients (n = 23) had no or only minor local infection, group II patients (n = 11) had infections with distinct systemic involvement, and group III patients (n = 7) developed sepsis. A first elastase-level of over 100 mg/L after surgery, followed by a drop in the amount of blood PMNs ready to migrate, on FMLP stimulation, to below 12 %, turned out to be a marker for impending infection, whereas all other parameters tested were not predictive. In six of seven group III patients, this marker became positive (sensitivity 85.7 %) up to 15 days before clinical manifestation of sepsis. In group I (largely uneventful recovery) only one of 23 patients was positive (specificity 95.6 % ), whereas group II patients were in between (4 of 11 positive). By this method it seems possible to diagnose severe infections in the pre-clinical phase, which may help prevent them if treatment is begun promptly.